Delivery Order SPE2DB24D2100-SPE2DB25FBEDJ
Award Date
5/14/25
Potential Completion Date
5/15/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,764.10, is for the delivery of Rocuronium 50 mg/5 ml vials. This is a firm fixed-price, delivery order contract with a period of performance through March 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,550,071 units of Rocuronium 100 mg/10 ml vials. The $1,231.45 fixed-price contract has an ultimate completion date of August 23, 2024. The award is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, has been a significant provider of critical medical commodities to various federal...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Rocuronium 50 mg/5 ml vials. The $1,374.24 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,174.40 firm fixed-price delivery order is for the supply of 4566581070 ROCURONIUM 100 MG/10 ML VIAL 10ML, with a completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide 4,565,704,171 units of the drug Rocuronium 50 mg/5 ml vial. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order valued at $1,813.95. The contract has no set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a...
This is a $1,191.19 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,212,256 units of Rocuronium 100 mg/10 ml vials. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 50 mg/5 mL vials of the drug Rocuronium. The contract has a ceiling value of $3,752.99 and an ultimate completion date of December 26, 2024. The contract is not designated as a set-aside procurement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the supply of 4567389512 - ROCURONIUM 100 MG/10 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025, with a ceiling value of $2,837.58 and a completion date of February 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen), a major pharmaceutical distributor, involves the delivery of 4565332483 - ROCURONIUM 50 MG/5 ML VIAL 5ML to the Defense Logistics Agency (DLA). The firm-fixed-price Delivery Order, valued at $1,846.80, has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,104.49, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, is for the delivery of ROCURONIUM 50 MG/5 ML VIAL 5ML, a medical supply. The contract has a period of performance through November 21, 2023 and is a Firm Fixed...